{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:32:48Z","timestamp":1773790368175,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.ejps.2017.06.032","type":"journal-article","created":{"date-parts":[[2017,6,27]],"date-time":"2017-06-27T04:30:34Z","timestamp":1498537834000},"page":"54-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Freeze dried solid dispersion of exemestane: A way to negate an aqueous solubility and oral bioavailability problems"],"prefix":"10.1016","volume":"107","author":[{"given":"Shamandeep","family":"Kaur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunil K.","family":"Jena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjaya K.","family":"Samal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vaishali","family":"Saini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7281-3252","authenticated-orcid":false,"given":"Abhay T.","family":"Sangamwar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2017.06.032_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/10717544.2014.976892","article-title":"Bile salts-containing vesicles: promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide\/protein-based therapeutics or vaccines","author":"Aburahma","year":"2014","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2017.06.032_bb0010","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.colsurfb.2009.03.029","article-title":"Solubilization of resveratrol in micellar solutions of different bile acids","volume":"72","author":"Atanackovic","year":"2009","journal-title":"Colloids Surf. B: Biointerfaces"},{"key":"10.1016\/j.ejps.2017.06.032_bb0015","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijpharm.2014.03.023","article-title":"Solid phospholipid nano-particles: investigations into formulation and dissolution properties of griseofulvin","volume":"467","author":"Brinkmann-Trettenes","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejpb.2009.06.001","article-title":"Lipid \u2013 an emerging platform for oral delivery of drugs with poor bioavailability","volume":"73","author":"Chakraborty","year":"2009","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0025","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-2275(20)41534-2","article-title":"Bile acid and sterol solubilization in 2-hydroxypropyl-beta-cyclodextrin","volume":"33","author":"De Caprio","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejps.2017.06.032_bb0030","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1111\/jphp.12644","article-title":"Alpha-lipoic acid-stearylamine conjugate-based solid lipid nanoparticles for tamoxifen delivery: formulation, optimization, in-vivo pharmacokinetic and hepatotoxicity study","volume":"68","author":"Dhaundiyal","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.032_bb0035","first-page":"1653","article-title":"Bile salt\/phospholipid mixed micelle precursorpellets prepared by fluid-bed coating","volume":"8","author":"Dong","year":"2013","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2017.06.032_bb0045","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1007\/s11095-010-0130-x","article-title":"Phospholipids and lipid-based formulations in oral drug delivery","volume":"27","author":"Fricker","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.06.032_bb0050","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0939-6411(98)00037-X","article-title":"Increasing drug solubility by means of bile salt\u2013phosphatidylcholine-based mixed micelles","volume":"46","author":"Hammad","year":"1998","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0055","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijpharm.2009.07.008","article-title":"Proliposomes of exemestane for improved oral delivery: formulation and in vitro evaluation using PAMPA, Caco-2 and rat intestine","volume":"380","author":"Hiremath","year":"2009","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2014.06.056","article-title":"Development of tamoxifen-phospholipid complex: novel approach for improving solubility and bioavailability","volume":"473","author":"Jena","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0065","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1111\/jphp.12422","article-title":"Modulation of tamoxifen induced hepatotoxicity by tamoxifen-phospholipid complex","volume":"67","author":"Jena","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.032_bb0070","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ejps.2017.02.023","article-title":"Potential of amphiphilic graft copolymer \u03b1-tocopherol succinate-g-carboxymethyl chitosan in modulating the permeability and anticancer efficacy of tamoxifen","volume":"101","author":"Jena","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.06.032_bb0075","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.apsb.2013.10.001","article-title":"Oral lipid-based drug delivery systems \u2013 an overview","volume":"3","author":"Kalepu","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2017.06.032_bb0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s12645-013-0037-4","article-title":"Encapsulation of exemestane in polycaprolactone nanoparticles: optimization, characterization, and release kinetics","volume":"4","author":"Kumar","year":"2013","journal-title":"Cancer Nanotechnol."},{"key":"10.1016\/j.ejps.2017.06.032_bb0085","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1016\/j.jconrel.2013.08.037","article-title":"Preparation, optimization and characterization of exemestane loaded PEGylated PCL nanoparticles for tumor targeting","volume":"172","author":"Kumar","year":"2013","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2017.06.032_bb0090","article-title":"Poly(D, L lactide-co-glycolide)\/montmorillonite nanoparticles for improved oral delivery of exemestane","volume":"1-9","author":"Li","year":"2013","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2017.06.032_bb0095","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ajps.2014.09.004","article-title":"A review on phospholipids and their main applications in drug delivery systems","volume":"10","author":"Li","year":"2015","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2017.06.032_bb0100","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.ijpharm.2006.09.025","article-title":"Curcumin\u2013phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats","volume":"330","author":"Maiti","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0105","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1021\/bi00545a001","article-title":"Quasielastic light-scatteringstudies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions","volume":"19","author":"Mazer","year":"1980","journal-title":"Biochemist"},{"key":"10.1016\/j.ejps.2017.06.032_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0378-5173(00)00526-3","article-title":"A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt:fatty acid micellar systems using the CaCo-2 cell culture model","volume":"207","author":"Meaney","year":"2000","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0115","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1021\/cm970251f","article-title":"Preparation of calcium-loaded liposomes and their use in calcium phosphate formation","volume":"10","author":"Messersmith","year":"1998","journal-title":"Chem. Mater."},{"key":"10.1016\/j.ejps.2017.06.032_bb0120","doi-asserted-by":"crossref","first-page":"14451","DOI":"10.3390\/molecules200814451","article-title":"Absorption-enhancing effects of bile salts","volume":"20","author":"Moghimipour","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ejps.2017.06.032_bb0125","doi-asserted-by":"crossref","first-page":"20140459","DOI":"10.1098\/rsif.2014.0459","article-title":"Liposomes in tissue engineering and regenerative medicine","volume":"11","author":"Monteiro","year":"2014","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.ejps.2017.06.032_bb0130","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1111\/j.2042-7158.2010.01107.x","article-title":"New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs","volume":"62","author":"Mullertz","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.032_bb0135","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1111\/jphp.12358","article-title":"Preparation, in-vitro and in-vivo evaluation of spray-dried ternary solid dispersion of biopharmaceutics classification system class II model drug","volume":"67","author":"Paidi","year":"2015","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.032_bb0140","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1080\/10717540500395007","article-title":"Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone","volume":"13","author":"Potluri","year":"2006","journal-title":"Drug Deliv."},{"key":"10.1016\/j.ejps.2017.06.032_bb0145","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1023\/A:1018905927544","article-title":"The influence of sucrose, dextran, and hydroxypropyl-\u03b2-cyclodextrin as lyoprotectants for a freeze-dried mouse IgG2a monoclonal antibody (MN12)","volume":"9","author":"Ressing","year":"1992","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.06.032_bb0150","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.ijpharm.2009.12.018","article-title":"Mixed micelle formation with phosphatidylcholines: the influence of surfactants with different molecule structures","volume":"387","author":"Rupp","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0155","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2478\/v10007-009-0023-x","article-title":"Development and physicochemical evaluation of pharmacosomes of diclofenac","volume":"59","author":"Semalty","year":"2009","journal-title":"Acta Pharma."},{"key":"10.1016\/j.ejps.2017.06.032_bb0160","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-008-9080-6","article-title":"Exemestane Loaded Self-microemulsifying Drug Delivery System (SMEDDS): development and optimization","volume":"9","author":"Singh","year":"2008","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejps.2017.06.032_bb0165","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jconrel.2005.05.016","article-title":"Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts","volume":"106","author":"Song","year":"2005","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2017.06.032_bb0170","first-page":"3689","article-title":"Nimodipine-loaded mixed micelles: formulation, compatibility, pharmacokinetics, and vascular irritability study","volume":"7","author":"Song","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ejps.2017.06.032_bb0175","doi-asserted-by":"crossref","DOI":"10.1023\/A:1015807913934","article-title":"Mixed miselles as proliposomal, lymphotropic drug carrier","volume":"8","author":"Supersaxo","year":"1991","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejps.2017.06.032_bb0180","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1208\/s12249-012-9772-9","article-title":"Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability","volume":"13","author":"Tan","year":"2012","journal-title":"AAPS PharmSci"},{"key":"10.1016\/j.ejps.2017.06.032_bb0185","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.2147\/TCRM.S4007","article-title":"Exemestane in early breast cancer: a review","volume":"4","author":"Untch","year":"2008","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.ejps.2017.06.032_bb0190","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1365-2125.2005.02335.x","article-title":"A predictive model for exemestane pharmacokinetics\/pharmacodynamics incorporating the effect of food and formulation","volume":"59","author":"Valle","year":"2005","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejps.2017.06.032_bb0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2010.07.046","article-title":"Alternative oral exemestane formulation: improved dissolution and permeation","volume":"398","author":"Yavuz","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2017.06.032_bb0200","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/aps.2010.55","article-title":"Enhancement of oral bioavailability of the poorly water-soluble drug silybin by sodium cholate\/phospholipid-mixed micelles","volume":"31","author":"Yu","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejps.2017.06.032_bb0205","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ejps.2015.06.007","article-title":"Proliposomes containing a bile salt for oral delivery of Ginkgo biloba extract: formulation optimization, characterization, oral bioavailability and tissue distribution in rats","volume":"77","author":"Zheng","year":"2015","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717303822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098717303822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T02:00:30Z","timestamp":1659146430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098717303822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":40,"alternative-id":["S0928098717303822"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2017.06.032","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Freeze dried solid dispersion of exemestane: A way to negate an aqueous solubility and oral bioavailability problems","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2017.06.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}